Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
rucaparib 300 MG Oral Tablet
Known as:
RUCAPARIB 300MG TAB
, RUCAPARIB 300MG TAB [VA Product]
, rucaparib (as rucaparib camsylate) 300 MG Oral Tablet
National Institutes of Health
Create Alert
Related topics
Related topics
3 relations
Oral Tablet
Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
rucaparib
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
LE Dockery
,
C. Gunderson
,
K. Moore
OncoTargets and therapy
2017
Corpus ID: 13924056
Rucaparib camsylate (CO-338, AG-014699, PF-01367338) is a potent PARP-1, PARP-2, and PARP-3 inhibitor. Phase I and II studies…
Expand
Review
2016
Review
2016
Evaluation of rucaparib and companion diagnostics in the PARP inhibitor landscape for recurrent ovarian cancer therapy.
Zachary B. Jenner
,
A. Sood
,
R. Coleman
Future oncology
2016
Corpus ID: 43263491
Rucaparib camsylate (CO-338; 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one ((1S…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE